SESSION III – PHARMACOVIGILANCE
The evolution of important safety communications
SALA DEL CASTELLO 2
15:15-18:15

In recent years, important safety communications (NIIS) have become one of the most common tools for informing patients and healthcare professionals about the potential risks associated with a medicine. Both at European and national level, agencies have developed new communication models that are increasingly efficient and effective, thanks in part to the advent of the digital age.
The pharmacovigilance group will present how close collaboration between all stakeholders (pharmaceutical companies, AIFA, patient associations, and healthcare professionals) can lead to an improvement in the process with positive results for all parties involved.
Grazie alla partecipazione di AIFA, di rappresentanti di associazioni pazienti e associazioni di operatori sanitari e della presenza di esperti del mondo farmaceutici e dei rappresentanti (Farmindustria, Assosalute ed Egualia) si potrà avere un aggiornamento del panorama farmaceutico sul tema dei materiali educazionali